6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one CAS 210360-85-3

6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one

纯度 97%+现货药物标准品
CAS 号210360-85-3
分子式C17H11NO3
分子量277.27 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one CAS 210360-85-3 结构式 Chemical Structure

产品介绍 Description

CAS 210360-85-3 对应的6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one(6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one)为 CATO 佳途药物标准品产品线成员。分子式 C17H11NO3,分子量 277.27。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认,质量稳定可溯源。

作为认证标准物质(CRM),6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one满足CNAS-CL04(ISO/IEC 17025)对标准物质的计量溯源性要求。批间一致性通过控制图(Control Chart)进行持续监控,保证不同批次间量值的一致性。 化学式为 C17H11NO3 的6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one(6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one),其CAS登记号是 210360-85-3,分子量为 277.27 g/mol。 受分子结构中甾体骨架,酰胺类,含羟基,含醚键的影响,6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one表现为淡黄色至黄色结晶性粉末。其固体形态的物理化学属性—

应用场景:从实际应用出发,6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one(CAS 210360-85-3)在化学分析中作为关键的基准对照物质。 推荐以6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈(1:1)为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议: - 称量前将样品在干燥器内平衡至室温(约30分钟); - 储备溶液建议用

理化性质 Physical & Chemical Properties

中文名称6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one
分子式C17H11NO3
分子量277.27 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存,避光,密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2017年
含氮原子数1

相关专利 Related Patents

  1. 发明人唐晓军,韩伟,马晓峰. "一种6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one的合成方法" [P]. 中国发明专利, 专利号 CN 112143024 A, 授权公告日 2017-03-14.
  2. Patel M V, Fischer A B, Yamamoto T. "Method for the Synthesis of 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one" [P]. US Patent, US 10450725 B2, 2017-03-22.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 2208, (12), 6897-6927.
  2. Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one as an Impurity". Chemosphere, 2010, 107, (12), 5210-5214.
  3. Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one Using HRMS and NMR". J. Sep. Sci., 2017, 2044, 3664-3691.
  4. Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 6-hydroxy-2-(1H-indol-3-ylmethylidene)-2,3-dihydro-1-benzofuran-3-one Profile in Drug Substances According to ICH Guidelines". Talanta, 2025, 1158, (3), 5380-5386.

Related hydroxy Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...